Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea C Klaver

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Immunopharmacology|September 26, 2017
Polyvalent immunoglobulin binding is an obstacle to accurate measurement of specific antibodies with ELISA despite inclusion of blocking agentsDavid A Loeffler, Andrea C Klaver
International Immunopharmacology|September 3, 2015
ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin productsDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Autoimmunity|November 14, 2014
Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administrationDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Experimental Gerontology|April 28, 2015
Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary reportDavid A Loeffler, Lynnae M Smith, Andrea C Klaver, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
Journal of Neuroscience Methods|December 18, 2010
Specificity and sensitivity of the Abeta oligomer ELISAAndrea C Klaver, Lynnae M Patrias, John M Finke, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Immunopharmacology|September 26, 2017
Polyvalent immunoglobulin binding is an obstacle to accurate measurement of specific antibodies with ELISA despite inclusion of blocking agentsDavid A Loeffler, Andrea C Klaver
International Immunopharmacology|September 3, 2015
ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin productsDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Autoimmunity|November 14, 2014
Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administrationDavid A Loeffler, Andrea C Klaver, Mary P Coffey
Experimental Gerontology|April 28, 2015
Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary reportDavid A Loeffler, Lynnae M Smith, Andrea C Klaver, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
Journal of Neuroscience Methods|December 18, 2010
Specificity and sensitivity of the Abeta oligomer ELISAAndrea C Klaver, Lynnae M Patrias, John M Finke, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Pageof 3